Patent Yard Sign in
Expired Canadian patentCanada

Arylmorpholine, preparation and use

CA 2108967 C · Owner: Kelley, James L. · Inventors: Mehta, Nariman B.; Boswell, Grady E.; Kelley, James L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel morpholines of formula (I) and their salts wherein R and R1 are each , either hydrogen or fluorine and R2 is hydrogen or methyl. The compounds have a variety of uses in human medicine in , particular in the treatment of mental disorders such as depression.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 22, 1992 and granted October 8, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 22, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 22, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 22, 1992
GrantedOctober 8, 2002
Term endedApril 22, 2012
Patent numberCA 2108967 C
Classification (IPC)C07D265/30 +1 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedApril 22, 1992Patent grantedOct 8, 2002Term endedApril 22, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.